openSANTA BARBARA, CA

Type 5 secretion as a novel mechanism to deliver protein effectors directly into mammalian host cells

National Institute of Allergy and Infectious Diseases

Description

All host-adapted Bordetella species encode large filamentous hemagglutinin-like adhesins termed FhaL. Global expression studies indicate that fhaL is a virulence-activated gene, and FhaL peptides are detected in the secretome of B. pertussis cells cultured under pathogenic growth conditions. Although the FhaL expression profile suggests a function during host colonization, the activity of this putative adhesin has not been examined experimentally. We find that FhaL has a remarkably similar domain architecture as antibacterial CdiA effector proteins, which deliver C-terminal toxin domains into neighboring bacteria to inhibit target-cell growth. We propose the FhaL uses a similar delivery mechanism to translocate putative effector domains into eukaryotic host cells. FhaL carries four cargo modules, each composed of C80 cysteine peptidase and putative effector domains. The peptidase domains are homologous to auto-proteolytic domains found in MARTX toxins, suggesting that FhaL releases it effector domains through auto-processing after translocation into the host cell cytosol. FhaL effector domains share between 25% and 45% pair-wise identity with each other, but are not homologous to any other protein of known function. AlphaFold2 modeling indicates that the effector domains adopt similar folds with distant structural homology to esterases and hydrolases. This project will determine whether FhaL acts as a contact-dependent effector delivery system and test whether the effector domains act as toxic hydrolases to disrupt host cell physiology. Project Number: 1R21AI191036-01 | Fiscal Year: 2025 | NIH Institute/Center: National Institute of Allergy and Infectious Diseases (NIAID) | Principal Investigator: Christopher Hayes | Institution: UNIVERSITY OF CALIFORNIA SANTA BARBARA, SANTA BARBARA, CA | Award Amount: $410,497 | Activity Code: R21 | Study Section: Prokaryotic Cell and Molecular Biology Study Section[PCMB] View on NIH RePORTER: https://reporter.nih.gov/project-details/1R21AI19103601

Interested in this grant?

Sign up to get match scores, save grants, and start your application with AI-powered tools.

Start Free Trial

Grant Details

Funding Range

$410,497 - $410,497

Deadline

June 30, 2027

Geographic Scope

SANTA BARBARA, CA

Status
open

External Links

View Original Listing

Want to see how well this grant matches your organization?

Get Your Match Score

Get personalized grant matches

Start your free trial to save opportunities, get AI-powered match scores, and manage your applications in one place.

Start Free Trial